Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65

David C. Seldin, Jennifer J. Anderson, Martha Skinner, Karim Malek, Daniel G. Wright, Karen Quillen, Kathleen Finn, Betul Oran, Vaishali Sanchorawala

Blood (2006) 108 (12): 3945–3947.

https://doi.org/10.1182/blood-2006-06-029728

Published: 2006

Journal Articles

Association of Acquired Von Willebrand Syndrome with Primary (AL) Amyloidosis.

Cynthia A. Kos, MA, Jennifer E. Ward, Karim Malek, MD, Vaishali Sanchorawala, MD, Daniel G. Wright, MD, Carl O’Hara, MD, Lawreen Connors, Ph.D, Martha Skinner, MD, David C. Seldin, MD

Blood (2005) 106 (11): 4078.

https://doi.org/10.1182/blood.V106.11.4078.4078

Published: 2005

Journal Articles

Feasibility of Second Autologous Peripheral Blood Stem Cell (PBSC) Collection Followed by a Second Cycle of High Dose Melphalan (HDM) in Patients Relapsing after an Initial Course of HDM for the Treatment of AL Amyloidosis.

Karen Quillen, MD, Daniel G. Wright, MD, David C. Seldin, MD PhD, Martha Skinner, MD, Karim Malek, MD, Kathleen T. Finn, RN, Vaishali Sanchorawala, MD

Blood (2004) 104 (11): 5226.

https://doi.org/10.1182/blood.V104.11.5226.5226

Published: 2004

Journal Articles

Successful Treatment of AL Amyloidosis Patients over Age 65 with High-Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT).

David Cary Seldin, MD, PhD, Jennifer J. Anderson, PhD, Martha Skinner, MD, Karim Malek, MD, Daniel G. Wright, MD, Karen Quillen, MD, Vaishali Sanchorawala, MD

Blood (2004) 104 (11): 923.

https://doi.org/10.1182/blood.V104.11.923.923

Published: 2004

Journal Articles

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation

David C. Seldin, Jennifer J. Anderson, Vaishali Sanchorawala, Karim Malek, Daniel G. Wright, Karen Quillen, Kathleen T. Finn, John L. Berk, Laura M. Dember, Rodney H. Falk, Martha Skinner

Blood (2004) 104 (6): 1888–1893.

https://doi.org/10.1182/blood-2004-01-0089

Published: 2004

Includes: Supplemental data

NARROW

Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65

Association of Acquired Von Willebrand Syndrome with Primary (AL) Amyloidosis.

Feasibility of Second Autologous Peripheral Blood Stem Cell (PBSC) Collection Followed by a Second Cycle of High Dose Melphalan (HDM) in Patients Relapsing after an Initial Course of HDM for the Treatment of AL Amyloidosis.

Successful Treatment of AL Amyloidosis Patients over Age 65 with High-Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT).

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65

Association of Acquired Von Willebrand Syndrome with Primary (AL) Amyloidosis.

Feasibility of Second Autologous Peripheral Blood Stem Cell (PBSC) Collection Followed by a Second Cycle of High Dose Melphalan (HDM) in Patients Relapsing after an Initial Course of HDM for the Treatment of AL Amyloidosis.

Successful Treatment of AL Amyloidosis Patients over Age 65 with High-Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT).

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only